NCT00687141 - Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Alzheimer's Disease

Interventions

DRUG

AZD0328

Oral solution administered orally once per day on day 1, and then day 3 through to day 14. Specific dose depends on dose panel.

DRUG

Placebo

Administered orally as a solution once per day on day 1, and then day 3 through to day 14.

Trial Locations (4)

Research Site, Linköping

Research Site, Luleå

Research Site, Stockholm

Research Site, Uppsala